The persistent exclusion of older patients from ongoing clinical trials regarding heart failure

Archives of Internal Medicine

Volumn 171, Issue 6, 2011, Pages 550-556

  Cherubini, Antonio ^a   Oristrell, Joaquim ^b   Pla, Xavier ^b   Ruggiero, Carmelinda ^a   Ferretti, Roberta ^a   Diestre, Germán ^b   Clarfield, A Mark ^c   Crome, Peter ^d   Hertogh, Cees ^e   Lesauskaite, Vita ^f   Prada, Gabriel Ioan ^g   Szczerbinska, Katarzyna ^h   Topinkova, Eva ⁱ   Sinclair Cohen, Judith ^j,k   Edbrooke, David ^j,k   Mills, Gary H ^j,k,l  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^d KEELE UNIVERSITY   (United Kingdom)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^g National Institute of Gerontology and Geriatrics   (Romania)

^h JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j Medical Economics and Research Centre   (United Kingdom)

^k ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^l SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CLINICAL TRIAL (TOPIC); DATA BASE; EUROPEAN UNION; HEART FAILURE; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED STATES;

AGED; AGED, 80 AND OVER; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; HEART FAILURE; HUMANS; LOGISTIC MODELS; PATIENT SELECTION;

EID: 79955162230     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.31     Document Type: Article

References (27)

1. Masoudi FA, Havranek EP, Krumholz HM. The burden of chronic congestive heart failure in older persons: magnitude and implications for policy and research. Heart Fail Rev. 2002;7(1):9-16.
2. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45(8):968-974.
3. Hall RE, Tu JV; Canadian Cardiovascular Outcomes Research Team. Hospitalization rates and length of stay for cardiovascular conditions in Canada, 1994 to 1999. Can J Cardiol. 2003;19(10):1123-1131.
4. Heiat A, Gross CP, Krumholz HM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162(15):1682-1688.
5. Masoudi FA, Havranek EP, Wolfe P, et al. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003;146(2):250-257.
6. Food and Drug Administration. Guideline for the study of drugs likely to be used in the elderly. Food and Drug Administration Web site. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072048.pdf. Accessed April 1, 2010.
7. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Studies in support of special populations: geriatric ICH E7, 1994. International Conference on Harmonisation Web site. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E7_Guideline.pdf. Accessed April 1, 2010.
8. Van Spall HGC, Toren A, Kiss A, et al. Eligibility criteria of randomized controlled clinical trials published in high-impact medical journals: a systematic sampling review. JAMA. 2007;297(11):1233-1240.
9. Bayer A, Tadd W. Unjustified exclusion of elderly people from studies submitted to research ethics committee for approval: descriptive study. BMJ. 2000;321(7267):992-993.
10. Bartlett C, Doyal L, Ebrahim S, et al. The causes and effects of sociodemographic exclusions from clinical trials. Health Technol Assess. 2005;9(38):1-152.
11. National Institutes of Health Revitalization Act of 1993 Subtitle B-Clinical Research Equity Regarding Women and Minorities. National Institutes of Health Web site. http://orwh.od.nih.gov/about/acrwh_news/Revitalization%20%20PDF%206-12-08.pdf. Accessed April 1, 2010.
12. Gurwitz JH, Col NF, Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268(11):1417-1422.
13. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA. Representation of older patients in cancer treatment trials. Cancer. 1994;74(7)(suppl):2208-2214.
14. Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061-2067.
15. Harris DJ, Douglas PS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med. 2000;343(7):475-480.
16. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716-724.
17. O'Hare AM, Kaufman JS, Covinsky KE, Landefeld CS, McFarland LV, Larson EB. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Intern Med. 2009;150(10):717-724.
18. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J. 2002;143(3):412-417.
19. Badano LP, Di Lenarda A, Bellotti P, Albanese MC, Sinagra G, Fioretti PM. Patients with chronic heart failure encountered in daily clinical practice are different from the "typical" patient enrolled in therapeutic trials. Ital Heart J. 2003;4(2):84-91.
20. Flather MD, Shibata MC, Coats AJ, et al; SENIORS Investigators. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215-225.
21. Massie BM, Carson PE, McMurray JJ, et al; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23):2456-2467.
22. Fosså SD, Skovlund E. Selection of patients may limit the generalizability of results from cancer trials. Acta Oncol. 2002;41(2):131-137.
23. Gross CP, Mallory R, Heiat A, Krumholz HM. Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med. 2002;137(1):10-16.
24. Wang OJ, Krumholz HM. Clinical trial participation: are we studying the patients we are trying to treat? Eur J Heart Fail. 2009;11(11):1021-1022.
25. Godlovitch G. Age discrimination in trials and treatment: old dogs and new tricks. Monash Bioeth Rev. 2003;22(3):66-77.
26. Witham MD, McMurdo ME. How to get older people included in clinical studies. Drugs Aging. 2007;24(3):187-196.
27. Neurology in the elderly: more trials urgently needed. Lancet Neurol. 2009;8(11):969.